The StrataNGS test has received coverage under Medicare by Palmetto GBA, a Medicare Administrative Contractor, for patients with advanced stages (III or IV), recurrent, relapsed, refractory, and/or metastatic solid tumors.
Urologic oncologist Wayne Brisbane thought his patient might be a good candidate for focal therapy.
